Kay-Hooi Khoo

Kay-Hooi Khoo

Auto-generated profile, based on publicly available information

Kay-Hooi Khoo

Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2016 in Nature Communications
Verified
Journal Article
Open access
CLChia-Wei Li
Chia-Wei Li
SLSeung-Oe Lim
Seung-Oe Lim
WXWeiya Xia
Weiya Xia
HLHeng-Huan Lee
Heng-Huan Lee
LCLi-Chuan Chan
Li-Chuan Chan
MHMien-Chie Hung
Mien-Chie Hung
Extracellular interaction between programmed death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) leads to tumour-associated immune escape. Here we show that the immunosuppression activity of PD-L1 is stringently modulated by ubiquitination and N-glycosylation. We show that glycogen synthase kinase 3β (GSK3β) interacts with PD-L1 and induces phosphorylation-dependent proteasome degradation of PD-L1 by β-TrCP. In-depth analysis of PD-L1 N192, N200 and N219 glycosylation suggests that glycosylation antagonizes GSK3β binding. In this regard, only non-glycosylated PD-L1 forms a complex with GSK3β and β-TrCP. We also demonstrate that epidermal growth factor (EGF) stabilizes PD-L1 via GSK3β inactivation in basal-like breast cancer. Inhibition of EGF signalling by gefitinib destabilizes PD-L1, enhances antitumour T-cell immunity and therapeutic efficacy of PD-1 blockade in syngeneic mouse models. Together, our results link ubiquitination and glycosylation pathways to the stringent regulation of PD-L1, which could lead to potential therapeutic strategies to enhance cancer immune therapy efficacy.

1 August 2018 in Molecular Cell
Verified
Journal Article
Closed access
JCJong-Ho Cha
Jong-Ho Cha
WYWen-Hao Yang
Wen-Hao Yang
WXWeiya Xia
Weiya Xia
YWYongkun Wei
Yongkun Wei
LCLi-Chuan Chan
Li-Chuan Chan
MHMien-Chie Hung
Mien-Chie Hung

1 February 2018 in Cancer Cell
Verified
Journal Article
Closed access
CLChia-Wei Li
Chia-Wei Li
SLSeung-Oe Lim
Seung-Oe Lim
ECEzra M. Chung
Ezra M. Chung
YKYong-Soo Kim
Yong-Soo Kim
APAndrew H. Park
Andrew H. Park
MHMien-Chie Hung
Mien-Chie Hung

15 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJung-Mao Hsu
Jung-Mao Hsu
WXWeiya Xia
Weiya Xia
YHYi-Hsin Hsu
Yi-Hsin Hsu
LCLi-Chuan Chan
Li-Chuan Chan
WYWen-Hsuan Yu
Wen-Hsuan Yu
MHMien-Chie Hung
Mien-Chie Hung
Enriched PD-L1 expression in cancer stem-like cells (CSCs) contributes to CSC immune evasion. However, the mechanisms underlying PD-L1 enrichment in CSCs remain unclear. Here, we demonstrate that epithelial–mesenchymal transition (EMT) enriches PD-L1 in CSCs by the EMT/β-catenin/STT3/PD-L1 signaling axis, in which EMT transcriptionally induces N-glycosyltransferase STT3 through β-catenin, and subsequent STT3-dependent PD-L1 N-glycosylation stabilizes and upregulates PD-L1. The axis is also utilized by the general cancer cell population, but it has much more profound effect on CSCs as EMT induces more STT3 in CSCs than in non-CSCs. We further identify a non-canonical mesenchymal–epithelial transition (MET) activity of etoposide, which suppresses the EMT/β-catenin/STT3/PD-L1 axis through TOP2B degradation-dependent nuclear β-catenin reduction, leading to PD-L1 downregulation of CSCs and non-CSCs and sensitization of cancer cells to anti-Tim-3 therapy. Together, our results link MET to PD-L1 stabilization through glycosylation regulation and reveal it as a potential strategy to enhance cancer immunotherapy efficacy.

27 June 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YLYing-Chih Liu
Ying-Chih Liu
HYHsin-Yung Yen
Hsin-Yung Yen
CCChien-Yu Chen
Chien-Yu Chen
CCChein-Hung Chen
Chein-Hung Chen
PCPing-Fu Cheng
Ping-Fu Cheng
CWChi-Huey Wong
Chi-Huey Wong
Protein glycosylation is an important posttranslational process, which regulates protein folding and functional expression. Studies have shown that abnormal glycosylation in tumor cells affects cancer progression and malignancy. In the current study, we have identified sialylated proteins using an alkynyl sugar probe in two different lung cancer cell lines, CL1-0 and CL1-5 with distinct invasiveness derived from the same parental cell line. Among the identified sialylated proteins, epidermal growth factor receptor (EGFR) was chosen to understand the effect of sialylation on its function. We have determined the differences in glycan sequences of EGFR in both cells and observed higher sialylation and fucosylation of EGFR in CL1-5 than in CL1-0. Further study suggested that overexpression of sialyltransferases in CL1-5 and α1,3-fucosyltransferases (FUT4 or FUT6) in CL1-5 and A549 cells would suppress EGFR dimerization and phosphorylation upon EGF treatment, as compared to the control and CL1-0 cells. Such modulating effects on EGFR dimerization were further confirmed by sialidase or fucosidase treatment. Thus, increasing sialylation and fucosylation could attenuate EGFR-mediated invasion of lung cancer cells. However, incorporation of the core fucose by α1,6-fucosylatransferase (FUT8) would promote EGFR dimerization and phosphorylation.

12 January 2007 in Glycobiology
Verified
Journal Article
Open access
PDF file
YWYoshinao Wada
Yoshinao Wada
PAParastoo Azadi
Parastoo Azadi
CCCatherine E Costello
Catherine E Costello
ADAnne Dell
Anne Dell
RDRaymond A. Dwek
Raymond A. Dwek
NTNaoyuki Taniguchi
Naoyuki Taniguchi
Mass spectrometry (MS) of glycoproteins is an emerging field in proteomics, poised to meet the technical demand for elucidation of the structural complexity and functions of the oligosaccharide components of molecules. Considering the divergence of the mass spectrometric methods employed for oligosaccharide analysis in recent publications, it is necessary to establish technical standards and demonstrate capabilities. In the present study of the Human Proteome Organisation (HUPO) Human Disease Glycomics/Proteome Initiative (HGPI), the same samples of transferrin and immunoglobulin-G were analyzed for N-linked oligosaccharides and their relative abundances in 20 laboratories, and the chromatographic and mass spectrometric analysis results were evaluated. In general, matrix-assisted laser desorption/ionization (MALDI) time-of-flight MS of permethylated oligosaccharide mixtures carried out in six laboratories yielded good quantitation, and the results can be correlated to those of chromatography of reductive amination derivatives. For underivatized oligosaccharide alditols, graphitized carbon-liquid chromatography (LC)/electrospray ionization (ESI) MS detecting deprotonated molecules in the negative ion mode provided acceptable quantitation. The variance of the results among these three methods was small. Detailed analyses of tryptic glycopeptides employing either nano LC/ESI MS/MS or MALDI MS demonstrated excellent capability to determine site-specific or subclass-specific glycan profiles in these samples. Taking into account the variety of MS technologies and options for distinct protocols used in this study, the results of this multi-institutional study indicate that MS-based analysis appears as the efficient method for identification and quantitation of oligosaccharides in glycomic studies and endorse the power of MS for glycopeptide characterization with high sensitivity in proteomic programs.